Imiquimod (R-837) and Resiquimod (R-838), two novel small-molecular-weight immune response modifiers, have similar structure. They have anti-virus and anti-tumor activities and can be used as B lymphocyte activators and adjuvants. They are widely used in dermatology to treat virus dermatoses and cutaneous benign or malignant tumors.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[application imiquimod
4
imiquimod resiquimod
4
resiquimod dermatology]
4
dermatology] imiquimod
4
imiquimod r-837
4
r-837 resiquimod
4
resiquimod r-838
4
r-838 novel
4
novel small-molecular-weight
4
small-molecular-weight immune
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!